Karo Healthcare is a dynamic and fast-growing company committed to enabling smarter choices in everyday healthcare. With a diverse portfolio spanning seven categories, we own and market more than 80 brands across approximately 90 countries. Our well-known brands include E45, Multi-Gyn, Pevaryl, Lamisil, and many more. Our core belief in empowering people to make intelligent health decisions drives our growth strategy, blending organic expansion and M&A. Join us at Karo Healthcare on our exciting journey.
To support our continued growth in Poland, we are looking for a Key Account Manager to join our Warsaw office.
This position plays a key part in building and strengthening Karo’s commercial presence in Poland. You will be responsible for managing a portfolio of key pharmacy chains, pharmaceutical wholesalers, and leading e-commerce customers, with a strong focus on the Polish market.
The role combines responsibilities across both brick-and-mortar pharmacy channels and e-commerce platforms, reflecting the omnichannel nature of our business. While e-commerce remains a key focus area, the scope has been expanded to include selected traditional pharmacy customers as well.
Requirements
Benefits
Karo Healthcare has a Diverse & Inclusive environment. We are looking for qualified candidates irrespective of gender, gender identity, sexual orientation, ethnicity, race, religion, national origin, disability or age.

Karo Healthcare delivers smart choices for everyday healthcare.
We own and commercialise branded, original over-the-counter products and prescription medicines across a range of everyday categories, including intimate health; skin health; digestive health, foot health; pain, cough and cold; wellness; and specialty products.
Our products are available in more than 90 countries and sold through pharmacies, retailers and via healthcare providers. We have our own sales organisation in more than 10 European countries, with the Nordic region as our core market.
Karo Healthcare is headquartered in Stockholm, Sweden, and owned by KKR since 2025.